Declan P. Doogan - Canterbury, GB2 Karen A. Scappaticci - New York NY Elizabeth Hackett - New York NY
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31135
US Classification:
514647
Abstract:
A method of treating anxiety-related disorders comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in preventing or alleviating anxiety and the symptoms associated with anxiety-related disorders.